Up on the tightrope: Natural killer cell activation and inhibition

Nature Immunology

Volumn 9, Issue 5, 2008, Pages 495-502

  Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD244 ANTIGEN; CD94 ANTIGEN; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE RECEPTOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN TYROSINE PHOSPHATASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CYTOTOXICITY; DOWNSTREAM PROCESSING; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TARGET CELL;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, CD; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TYROSINE;

EID: 42449102990     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1581     Document Type: Review

References (78)

1. Kärre, K., Ljunggren, H.G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675-678 (1986).
2. Ravetch, J.V. & Lanier, L.L. Immune inhibitory receptors. Science 290, 84-89 (2000).
3. Tessmer, M.S. et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int. Immunol. 19, 391-400 (2007).
4. Stebbins, C.C. et al. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 23, 6291-6299 (2003).
5. Alvarez-Arias, D.A. & Campbell, K.S. Protein kinase C regulates expressiog and function of inhibitory killer cell Ig-like receptors in NK cells. J. Immunol. 179, 5281-5290 (2007).
6. Bryceson, Y.T., March, M.E., Ljunggren, H.G. & Long, E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107, 159-166 (2005).
7. Feng, J., Garrity, D., Call, M.E., Moffett, H. & Wucherpfennig, K.W. Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. Immunity 22, 427-438 (2005).
8. Lanier, L.L., Yu, G. & Phillips, J.H. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342, 803-805 (1989).
9. Lanier, L.L., Yu, G. & Phillips, J.H. Analysis of FcγRIII (CD16) membrane expression and association with CD3ζ and FcεRI- by site-directed mutation. J. Immunol. 146, 1571-1576 (1991).
10. McVicar, D.W. et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J. Biol. Chem. 273, 32934-32942 (1998).
11. Colucci, F. et al. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat. Immunol. 3, 288-294 (2002).
12. Chiesa, S. et al. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107, 2364-2372 (2006).
13. Hesslein, D.G., Takaki, R., Hermiston, M.L., Weiss, A. & Lanier, L.L. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc. Natl. Acad. Sci. USA 103, 7012-7017 (2006).
14. Mason, L.H., Willette-Brown, J., Taylor, L.S. & McVicar, D.W. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J. Immunol. 176, 6615-6623 (2006).
15. Huntington, N.D., Xu, Y., Nutt, S.L. & Tarlinton, D,.M. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary NK cells. J. Exp. Med. 201, 1421-1433 (2005).
16. Tassi, I. et al. Phospholipase Cγ2 Is a critical signaling mediator for murine NK cell activating receptors. J. Immunol. 175, 749-754 (2005).
17. Cella, M. et al. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200 817-823 (2004).
18. Ting, A.T., Karnitz, L.M., Schoon, R.A., Abraham, R.T. & Leibson, P.J. Fcγ receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-γl and PLC-γ2 in natural killer cells. J. Exp. Med. 176, 1751-1755 (1992).
19. Billadeau, D.D. et al. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188, 549-559 (1998).
20. Paolini, R., Molfetta, R., Piccoli, M., Frati, L. & Santoni, A. Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement. Proc. Natl. Acad. Sci. USA 98, 9611-9616 (2001).
21. Galandrini, R. et al. SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. Blood 100, 4581-4589 (2002).
22. Houchins, J.P., Yabe, T., McSherry, C. & Bach, F.H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173, 1017-1020 (1991).
23. Bauer, S. et al. Activation of natural killer cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-730 (1999).
24. Jamieson, A.M. et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19-29 (2002).
25. Wu, J. et al. An activating receptor complex on natural killer and T cells formed by NKG2D and DAP10. Science 285, 730-732 (1999).
26. Diefenbach, A. et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3, 1142-1149 (2002).
27. Gilfillan, S., Ho, E.L., Cella, M., Yokoyama, W.M. & Colonna, M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol. 3, 1150-1155 (2002).
28. Rosen, U.B. et al. A structural basis for the association of DAP12 with mouse, but not human, NRG2D. J. Immunol. 173, 2470-2478 (2004).
29. Andre, P. et al. Comparative analysis of human NK cell activation induced by NIKG2D and natural cytotoxicity receptors. Eur. J. Immunol. 34, 961-971 (2004).
30. Garrity, D., Call, M.E., Feng, J. & Wucherpfennig, K.W. The activating NKG2D receptor assembles in the membrane with two signaling dinners into a hexameric structure. Proc. Natl. Acad. Sci. USA 102, 7641-7646 (2005).
31. Wu, J., Cherwinski, H., Spies, T., Phillips, J.H. & Lanier, L.L. DAP10 a6d DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192, 1059-1068 (2000).
32. Upshaw, J.L. et al. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat. Immunol. 7, 524-532 (2006).
33. Billadeau, D.D, Upshaw, J.L., Schoon, R.A., Dick, C.J. & Leibson, P.J. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4, 557-564 (2003).
34. Graham, D.B. et al. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. J. Immunol. 177, 2349-2355 (2006).
35. Giurisato, E. et al. Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse. Mol. Cell. Biol. 27, 8583-8599 (2007).
36. Zompi, S. et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4, 565-572 (2003).
37. Horng, T., Bezbradica, J.S. & Medzhitov, R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 8, 1345-1352 (2007).
38. Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357-366 (2004).
39. Sutherland, C.L. et al. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK calls. J. Immunol. 168, 671-679 (2002).
40. Kubin, M. et al. ULBP1, 2, 3: Novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur. J. Immunol. 31, 1428-1437 (2001).
41. + T cells. J. Immunol. 174, 1922-1931 (2005).
42. + T cells. Blood 103, 3065-3072 (2004).
43. Ma, C.S., Nichols, K.E. & Tangye, S.G. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev Immunol. 25, 337-379 (2007).
44. Veillette, A. NK cell regulation by SLAM family receptors and SAP-related adapteis. Immunol. Rev. 214, 22-34 (2006).
45. Veillette, A., Dong, Z. & Latour, S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 27, 698-710 (2007).
46. Valiante, N.M. & Trinchieri, G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178, 1397-1406 (1993).
47. Tangye, S.G. et al. Cutting edge: Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162, 6981-6985 (1999).
48. Bottino, C. et al. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194, 235-246 (2001).
49. Bouchon, A., Cella, M., Grierson, H.L., Cohen, J.I. & Colonna, M. Cutting edge: Activation of NK cell-mediated cytotoxicity by a SAP- independent receptor of the CD2 family. J. Immunol. 167, 5517-5521 (2001).
50. Mathew, P.A. et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol. 151 5328-5337 (1993).
51. Garni-Wagner, B.A., Purohit, A., Mathew, P.A., Bennett, M. & Kumar, K. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151, 60-70 (1993).
52. Schatzle, J.D. et al. Characterizatíon of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc. Natl. Acad. Sci. USA 96, 3870-3875 (1999).
53. Chen, R., Latour, S., Shi, X. & Veillette, A. Association between SAP and FynT: Inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor. Mol. Cell. Biol. 26, 5559-5568 (2006).
54. Roncagalli, R. et al. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat. Immunol. 6, 1002-1010 (2005).
55. Calpe, S. et al. Identification and charecterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters. Immunogenetics 58, 15-25 (2006).
56. Clarkson, N.G., Simmonds, S.J., Puklavec, M.J. & Brown, M.H. Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase, J. Biol. Chem. 282, 25385-25394 (2007).
57. Tangye, S.G., Phillips, J.H., Lanier, L.L. & Nichols, K.E. Cutting edge: functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165, 2932-2936 (2000).
58. Nakajima, H. et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30, 3309-3318 (2000).
59. Parolini, S. et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192, 337-346 (2000).
60. Bloch-Queyrat, C. et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J. Exp. Med. 202 181-192 (2005).
61. Lee, K.M. et al. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 199. 1245-1254 (2004).
62. Vaidya, S.V. et al. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J. Immunol. 174, 800-807 (2005).
63. Taniguchi, R.T., Guzior, D. & Kumar, V. 2B4 inhibits NK cell fratricide. Blood 110, 2020-2023 (2007).
64. Lee, K.M. et al. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood 107, 3181-3188 (2006).
65. Tangye, S.G., Cherwinski, H., Lanier, L.L. & Phillips, J.H. 2B4-mediated activation of human natural killer cells. Mol. Immunol. 37, 493-501 (2000).
66. Eissmann, P. et al. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105, 4722-4729 (2005).
67. Chen, R. et al. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol. Cell. Biol. 24, 5144-5156 (2004).
68. Watzl, C., Stebbins, C.C. & Long, E.O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165, 3545-3548 (2000).
69. Saborit-Villarroya, I. et al. The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing. J. Immunol. 175, 4226-4235 (2005).
70. Aoukaty, A. & Tan, R. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease. J. Immunol. 174, 4551-4558 (2005).
71. Chuang, S.S., Kumaresan, P.R. & Mathew, P.A. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol. 167, 6210-6216 (2001).
72. Aoukaty, A. & Tan, R. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J. Biol. Chem. 277, 13331-13337 (2002).
73. Klem, J., Verrett, P.C., Kumar, V. & Schatzle, J.D. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-emriched microdomains: Properties required for 2B4 lytic function. J. Immunol. 169, 55-62 (2002).
74. Bottino, C. et al. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: Evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol. 30, 3718-3722 (2000).
75. Watzl, C. & Long, E.O. Natural killer cell inhibitory receptors block actin cytoskeletal-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197, 77-85 (2003).
76. Wahle, J.A. et al. Cutting edge: Dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets. J. Immunol. 176, 7165-7169 (2006).
77. Wahle, J.A. et al. Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell. J. Immunol. 179, 8009-8015 (2007).
78. Bhat, R. & Watzl, C. Serial killing of tumor cells by human natural killer cells enhancement by therapeutic antibodies. PLoS ONE 2 e326 (2007).